Misleading serum free thyroxine results during low molecular weight heparin treatment
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Measured free thyroxine concentrations in serum increase markedly after intravenous heparin administration, but the effect of heparin administered subcutaneously has not been adequately documented. We found in vitro increases of up to 63% in measured FT4 after a single dose of subcutaneous heparin (enoxaparin, 2000 units) in nine healthy volunteers, and the magnitude of these increases was correlated with initial serum triglyceride concentrations (r = 0.93, P <0.005) and in vitro free fatty acid release (r = 0.88, P <0.005). In 10 cardiac inpatients receiving repeated doses of enoxaparin (2000 units twice daily), measured FT4 increased by up to 171% in specimens taken 2–6 h after injection. When specimens were obtained 10 h after injection, the effect appeared to be minimized, with in vitro increases of <40%, but such increases may still be sufficient to cause interpretative errors. If FT4 estimation is absolutely necessary in patients receiving enoxaparin, specimens should be taken ≥10 h postdose and analyzed within 24 h.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
JAUME, J. C., MENDEL, C. M., FROST, P. H., GREENSPAN, F. S., & LAUGHTON, C. W. (1996) · Thyroid · doi:10.1089/thy.1996.6.79 · Cited by 92 · cited 1×
“(9) reported a case of artifactual FT4 increase, by equilibrium dialysis measurement, in a patient receiving intralipid and subcutaneous heparin (5000 units).”
Background
Cited by
Pitfalls in the measurement and interpretation of thyroid function tests
Koulouri, O., Moran, C., Halsall, D., Chatterjee, K., & Gurnell, M. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.10.003 · Cited by 282
Burch, H. B. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1901214 · Cited by 164
Excess thyroid hormone and carbohydrate metabolism
Potenza, M., Via, M. A., & Yanagisawa, R. T. (2009) · Endocrine Practice · doi:10.4158/ep.15.3.254 · Cited by 155
DIAGNOSIS OF ENDOCRINE DISEASE: How reliable are free thyroid and total T3 hormone assays?
Welsh, K. J., & Soldin, S. J. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0193 · Cited by 124
Van Uytfanghe, K., Ehrenkranz, J., Halsall, D., Hoff, K., Loh, T. P., Spencer, C. A., Köhrle, J., & ATA Thyroid Function Tests Writing Group (2023) · Thyroid® · doi:10.1089/thy.2023.0169 · Cited by 100
What should be done when thyroid function tests do not make sense?: Atypical thyroid function tests
Gurnell, M., Halsall, D. J., & Chatterjee, V. K. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04023.x · Cited by 88
Stockigt, J. R., & Lim, C.-F. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.06.004 · Cited by 79
Abnormal serum free thyroid hormone levels due to heparin administration
Laji, K. (2001) · QJM · doi:10.1093/qjmed/94.9.471 · Cited by 37
Drug-induced endocrine disorders in the intensive care unit
Thomas, Z., Bandali, F., McCowen, K., & Malhotra, A. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181dda0f2 · Cited by 30
Welsh, K. J., Stolze, B. R., Yu, X., Podsiadlo, T. R., Kim, L. S., & Soldin, S. J. (2017) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2016.11.022 · Cited by 17
Assessing Thyroid Function in Hospitalized Patients
LoPresti, J. S., & Patil, K. S. (2010) · Endocrine Updates · doi:10.1007/978-1-4419-1485-9_10 · Cited by 3
Metadata
- Authors
- Stevenson, H. P., Pooler, G., Archbold, R., Johnston, P., Young, I. S., & Sheridan, B.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-05-01
- Volume
- 44
- Issue
- 5
- Pages
- 1002-1007
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2128828392
- Cited by
- 78
- References
- 1
- FWCI
- 2.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.